This morning, we hosted a 20-minute conference call to discuss the factors that led us to downgrade shares of Walgreens Boots and CVS Health as well as the analysis of the 340B Drug Discount Program profit contributions that catalyzed our more negative outlooks for WBA and CVS shares.